You can install our site as a web app on your iOS device by utilizing the Add to Home Screen feature in Safari. Please see this thread for more details on this.
Note: This feature may not be available in some browsers.
Looking forward, medicine is likely to become less tied to physical doctors' offices and to particular hospitals. Vital signs can increasingly be monitored from the home, and robotic surgeries (am aware of DaVinci machines by Intuitive Surgical - ISRG) are starting to be performed remotely. So, if you need surgery, it may in the future not be necessary to travel to a big-name hospital for the very best care. Instead, you'd consult with surgeons remotely, then check into a local hospital with the necessary surgical robot which would be operated by your top-notch surgeon from across the country.
Me too! I bought at about 12 bucks a few weeks ago then, I bought more on Friday when it dipped below ten bucks. Right after that it started taking off. Makes me feel like a genius.
Lemonade looks to be a good stock, founder CEO, and with high growth potential. PLTR was my last purchase other than TSLA.Great interview. I'm gonna double down on Lemonade in the New Year.
What other tech, uh.. I mean Pot Stock to consider?
Some time ago I bought three. ACB was a complete bust, I'm out and pretending it never happened. SMG (Scott's Miracle Grow) has been very good and IIPR (Innovative Industrial Properties) has been amazing.
IIPR is the one I want to talk about though because despite such a great run up, I think it's still undervalued. The company is an REIT that buys grow operations and leases back to the owners. This is a good arrangement because the owners need capital which they can't get from banks due to the Federal status of cannabis.
IIP is growing revenue and profits at a very fast pace and they're doing it with minimal debt. Their balance sheet really looks terrific. Legalization is going to continue to roll out over the next 5 to 10 years and IIP probably won't face serious competition until the Feds legalize. I think there's still massive growth ahead with revenues and profits continuing to grow exponentially.
Is there something I'm missing here or did I find a gem in the rough?
Any thoughts on Hyliion? Their CEO is pretty solid, they have actual sales and their business plan seems good. It came out as a SPAC then took a beating. According to their 10q it’s intrinsic value is $20 per share. But potentially a solid growth story.
I sort of punch myself for selling NIO ~ @$26 and earlier, but 5x - while not 10X is nothing to shake a stick at. At this point, those who are holding ( and there are many who bought in the $3-$7 ranges, I think our next target is $60... so stay frosty and have your plan. I started to scale when we got back to ~$11, but should have held those positions beyond $26..
Selling calls this year has been phenomenal no matter the stockI was selling calls against what I had, then sold half at high 40's for a bit over 2x gain. Selling short term calls against what is left in the $55-60 strikes, if it gets called away I probably am not going to re-enter unless it goes back down to low 40's. This looks like a stock that will act like Tesla 5 years ago, high expectations and possible big moves in valuation/risk plus swaying by hype and news cycle/trading. It will be interesting to see how this goes since there aren't any easily available aggregate data sources on the company like we have here with TSLA, so unless I'd be willing to spend copious amounts of time doing research best I can do is just assume it's gonna be volatile and have patience and willingness to walk away and wait if trades turn against me.
I don't think your moves were unreasonable and who knows, maybe you'll be able to re-enter at mid 20's although it doesn't look likely from here.
+60% todayArcimoto has doubled in a week. Still <$0.5Bn!